TRV
Third Rock Ventures Portfolio holdings
AUM
$1.07B
This Quarter Return
+9.95%
1 Year Return
+201.55%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$857M
AUM Growth
+$857M
(+83%)
Cap. Flow
+$384M
Cap. Flow
% of AUM
44.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$368M |
| 2 |
Larimar Therapeutics
LRMR
|
$110M |
Top Sells
| 1 |
Agios Pharmaceuticals
AGIO
|
$50.6M |
| 2 |
BLUE
bluebird bio
BLUE
|
$43.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
1
DELISTED
Sage Therapeutics
SAGE
| $368M | 42.92% |
+11,681,008
| New | +$368M |
|
|
2
Agios Pharmaceuticals
AGIO
$2.24B
| $188M | 21.97% |
3,070,090
-825,000
| -21% | -$50.6M |
|
|
3
Larimar Therapeutics
LRMR
$344M
| $110M | 12.84% |
+5,602,045
| New | +$110M |
|
|
FMI
4
DELISTED
Foundation Medicine, Inc.
FMI
| $93.4M | 10.9% |
4,927,234
| – | – |
|
5
Carisma Therapeutics
CARM
$19M
| $53.9M | 6.29% |
4,841,591
| – | – |
|
|
BLUE
6
DELISTED
bluebird bio
BLUE
| $43.6M | 5.09% |
1,215,054
-1,201,920
| -50% | -$43.1M |
|